Is This Under-the-Radar Growth Stock a Buy?
The healthcare sector spans a number of intriguing areas for investors. These include pharmaceuticals, health insurance, and medical devices. Within that last group sits AngioDynamics (NASDAQ: ANGO), a little-known company that makes devices for treating peripheral vascular disease.
No doubt, that is an important specialty. But is the small-cap stock a buy for growth investors today? Let's dig into AngioDynamics' fundamentals and valuation to address this question.
With a market capitalization of just $539 million, AngioDynamics is a medtech business that flies under the radar of most retail investors. Don't let that fool you, though.
Source Fool.com
